BIOMAT Database Logo BIOMAT Database Logo

D-penicillamine and lupus erythematosuslike syndrome. 1978

T M Harkcom, and D L Conn, and K E Holley

UI MeSH Term Description Entries
D008180 Lupus Erythematosus, Systemic A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow. Libman-Sacks Disease,Lupus Erythematosus Disseminatus,Systemic Lupus Erythematosus,Disease, Libman-Sacks,Libman Sacks Disease
D010396 Penicillamine 3-Mercapto-D-valine. The most characteristic degradation product of the penicillin antibiotics. It is used as an antirheumatic and as a chelating agent in Wilson's disease. Dimethylcysteine,Mercaptovaline,beta,beta-Dimethylcysteine,Copper Penicillaminate,Cuprenil,Cuprimine,D-3-Mercaptovaline,D-Penicillamine,Metalcaptase,D 3 Mercaptovaline,D Penicillamine,Penicillaminate, Copper,beta,beta Dimethylcysteine
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001172 Arthritis, Rheumatoid A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated. Rheumatoid Arthritis
D013577 Syndrome A characteristic symptom complex. Symptom Cluster,Cluster, Symptom,Clusters, Symptom,Symptom Clusters,Syndromes

Related Publications

T M Harkcom, and D L Conn, and K E Holley
D-penicillamine-induced lupus erythematosus.
October 1990, Arthritis and rheumatism,
T M Harkcom, and D L Conn, and K E Holley
D-penicillamine-induced lupus erythematosus.
October 1991, Arthritis and rheumatism,
T M Harkcom, and D L Conn, and K E Holley
Lupus-like syndrome induced by D-penicillamine in Wilson's disease.
February 1971, Lancet (London, England),
T M Harkcom, and D L Conn, and K E Holley
Letter: Goodpasture syndrome and D-penicillamine.
January 1976, Annals of internal medicine,
T M Harkcom, and D L Conn, and K E Holley
[Primary biliary cirrhosis and lupus: role of D-penicillamine?].
April 1982, Gastroenterologie clinique et biologique,
T M Harkcom, and D L Conn, and K E Holley
Systemic lupus erythematosus-like syndrome with focal proliferative glomerulonephritis during D-penicillamine therapy.
March 1993, British journal of rheumatology,
T M Harkcom, and D L Conn, and K E Holley
D-Penicillamine--induced pemphigus syndrome.
March 1982, Journal of the American Academy of Dermatology,
T M Harkcom, and D L Conn, and K E Holley
D-penicillamine in Felty's syndrome.
August 1985, The Journal of rheumatology,
T M Harkcom, and D L Conn, and K E Holley
D-penicillamine and the ocular myasthenic syndrome.
October 1981, Annals of ophthalmology,
T M Harkcom, and D L Conn, and K E Holley
[Moschcowitz's syndrome following D-penicillamine medication].
February 1975, Die Medizinische Welt,
Copied contents to your clipboard!